Neurofibromatosis Research Execution – Hypothesis-Driven Laboratory Studies
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract seeks to advance understanding of neurofibromatosis through innovative, hypothesis-driven laboratory research aimed at addressing high-impact scientific questions with the potential to reshape current paradigms in disease mechanisms or therapeutic approaches. The work requires rigorous experimental design, comprehensive data collection and analysis, and clear reporting of findings, all focused on generating transformative insights that could lead to novel treatments or diagnostic strategies. This subcontract is issued by the Defense Health Agency Contracting Activity under the Department of Defense and falls under NAICS code 541715 for research and development in the physical, engineering, and life sciences. Proposals must be submitted by September 22, 2026, with the research expected to be conducted at the performer’s facility, though the specific location is not designated. The initiative prioritizes originality and scientific impact over incremental progress, demanding a strong theoretical foundation and the potential to significantly alter the landscape of neurofibromatosis research.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Health Agency Contracting Activity - Dhaca
Same awarding agency
